Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1993 Apr 1;291(Pt 1):157–161. doi: 10.1042/bj2910157

Regulation of the receptor for platelet-activating factor on human platelets.

J A Burgers 1, J W Akkerman 1
PMCID: PMC1132495  PMID: 8385926

Abstract

Human platelets possess about 300 receptors for platelet-activating factor (PAF) per cell with a Kd of about 0.2 nM. In the present study we investigated whether these receptors are subject to intracellular control mechanisms. Preincubation with the protein kinase C inhibitor staurosporine had no effect, and also agents that increase cyclic AMP failed to change the binding of [3H]PAF. The Ca(2+)-calmodulin inhibitors W-7 and sphingosine decreased PAF binding by 50-80%. Inhibition of energy metabolism induced a fall in adenylate energy charge [AEC = ([ATP] + 1/2[ADP])([ATP + ADP + AMP])] and an almost parallel decrease in specific [3H]PAF binding without changing the Kd. Restoration of the AEC restored the [3H]PAF binding. Abrupt arrest of energy metabolism during binding of [3H]PAF left the binding unchanged until the metabolic ATP level had decreased by about 90%. These data indicate that PAF receptors on human platelets are under close intracellular control, possibly via a Ca(2+)-calmodulin-dependent phosphorylation/dephosphorylation process.

Full text

PDF
158

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akkerman J. W., Gorter G. Relation between energy production and adenine nucleotide metabolism in human blood platelets. Biochim Biophys Acta. 1980 Mar 7;590(1):107–116. doi: 10.1016/0005-2728(80)90150-4. [DOI] [PubMed] [Google Scholar]
  2. Avdonin P. V., Svitina-Ulitina I. V., Kulikov V. I. Stimulation of high-affinity hormone-sensitive GTPase of human platelets by 1-O-alkyl-2-O-acetyl-sn-glyceryl-3-phosphocholine (platelet activating factor). Biochem Biophys Res Commun. 1985 Aug 30;131(1):307–313. doi: 10.1016/0006-291x(85)91803-0. [DOI] [PubMed] [Google Scholar]
  3. Brass L. F., Woolkalis M. J., Manning D. R. Interactions in platelets between G proteins and the agonists that stimulate phospholipase C and inhibit adenylyl cyclase. J Biol Chem. 1988 Apr 15;263(11):5348–5355. [PubMed] [Google Scholar]
  4. Chao W., Liu H. L., Zhou W. G., Hanahan D. J., Olson M. S. Regulation of platelet-activating factor receptor and platelet-activating factor receptor-mediated biological responses by cAMP in rat Kupffer cells. J Biol Chem. 1990 Oct 15;265(29):17576–17583. [PubMed] [Google Scholar]
  5. Chao W., Liu H., Hanahan D. J., Olson M. S. Regulation of platelet-activating factor receptor and PAF receptor-mediated arachidonic acid release by protein kinase C activation in rat Kupffer cells. Arch Biochem Biophys. 1990 Oct;282(1):188–197. doi: 10.1016/0003-9861(90)90103-6. [DOI] [PubMed] [Google Scholar]
  6. Chao W., Liu H., Hanahan D. J., Olson M. S. Regulation of platelet-activating factor receptors in rat Kupffer cells. J Biol Chem. 1989 Dec 5;264(34):20448–20457. [PubMed] [Google Scholar]
  7. Chau L. Y., Tsai Y. M., Cheng J. R. Photoaffinity labeling of platelet activating factor binding sites in rabbit platelet membranes. Biochem Biophys Res Commun. 1989 Jun 30;161(3):1070–1076. doi: 10.1016/0006-291x(89)91352-1. [DOI] [PubMed] [Google Scholar]
  8. Crouch M. F., Lapetina E. G. Dual mechanisms of platelet hormone receptor desensitization. Differential importance between agonists of protein kinase C-dependent and -independent pathways. J Biol Chem. 1989 Jan 5;264(1):584–588. [PubMed] [Google Scholar]
  9. Dohlman H. G., Caron M. G., Lefkowitz R. J. A family of receptors coupled to guanine nucleotide regulatory proteins. Biochemistry. 1987 May 19;26(10):2657–2664. doi: 10.1021/bi00384a001. [DOI] [PubMed] [Google Scholar]
  10. Filep J. G., Földes-Filep E. Inhibition by calcium channel blockers of the binding of platelet-activating factor to human neutrophil granulocytes. Eur J Pharmacol. 1990 Nov 6;190(1-2):67–73. doi: 10.1016/0014-2999(90)94113-c. [DOI] [PubMed] [Google Scholar]
  11. Homma H., Hanahan D. J. Attenuation of platelet activating factor (PAF)-induced stimulation of rabbit platelet GTPase by phorbol ester, dibutyryl cAMP, and desensitization: concomitant effects on PAF receptor binding characteristics. Arch Biochem Biophys. 1988 Apr;262(1):32–39. doi: 10.1016/0003-9861(88)90165-8. [DOI] [PubMed] [Google Scholar]
  12. Honda Z., Nakamura M., Miki I., Minami M., Watanabe T., Seyama Y., Okado H., Toh H., Ito K., Miyamoto T. Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung. Nature. 1991 Jan 24;349(6307):342–346. doi: 10.1038/349342a0. [DOI] [PubMed] [Google Scholar]
  13. Houslay M. D., Bojanic D., Wilson A. Platelet activating factor and U44069 stimulate a GTPase activity in human platelets which is distinct from the guanine nucleotide regulatory proteins, Ns and Ni. Biochem J. 1986 Mar 15;234(3):737–740. doi: 10.1042/bj2340737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hwang S. B. Identification of a second putative receptor of platelet-activating factor from human polymorphonuclear leukocytes. J Biol Chem. 1988 Mar 5;263(7):3225–3233. [PubMed] [Google Scholar]
  15. Jefferson A. B., Schulman H. Sphingosine inhibits calmodulin-dependent enzymes. J Biol Chem. 1988 Oct 25;263(30):15241–15244. [PubMed] [Google Scholar]
  16. Kaji H., Casnellie J. E., Hinkle P. M. Thyrotropin releasing hormone action in pituitary cells. Protein kinase C-mediated effects on the epidermal growth factor receptor. J Biol Chem. 1988 Sep 25;263(27):13588–13593. [PubMed] [Google Scholar]
  17. Kilkson H., Holme S., Murphy S. Platelet metabolism during storage of platelet concentrates at 22 degrees C. Blood. 1984 Aug;64(2):406–414. [PubMed] [Google Scholar]
  18. Kloprogge E., Akkerman J. W. Binding kinetics of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) to intact human platelets. Biochem J. 1984 Nov 1;223(3):901–909. doi: 10.1042/bj2230901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kroegel C., Yukawa T., Westwick J., Barnes P. J. Evidence for two platelet activating factor receptors on eosinophils: dissociation between PAF-induced intracellular calcium mobilization degranulation and superoxides anion generation in eosinophils. Biochem Biophys Res Commun. 1989 Jul 14;162(1):511–521. doi: 10.1016/0006-291x(89)92027-5. [DOI] [PubMed] [Google Scholar]
  20. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  21. Lapetina E. G., Siegel F. L. Shape change induced in human platelets by platelet-activating factor. Correlation with the formation of phosphatidic acid and phosphorylation of a 40,000-dalton protein. J Biol Chem. 1983 Jun 25;258(12):7241–7244. [PubMed] [Google Scholar]
  22. Lerea K. M., Glomset J. A., Krebs E. G. Agents that elevate cAMP levels in platelets decrease thrombin binding. J Biol Chem. 1987 Jan 5;262(1):282–288. [PubMed] [Google Scholar]
  23. Mollon J. G protein-coupled receptors. Hue and the heptahelicals. Nature. 1991 Jun 27;351(6329):696–697. doi: 10.1038/351696a0. [DOI] [PubMed] [Google Scholar]
  24. Ng D. S., Wong K. Specific binding of platelet-activating factor (PAF) by human peripheral blood mononuclear leukocytes. Biochem Biophys Res Commun. 1988 Aug 30;155(1):311–316. doi: 10.1016/s0006-291x(88)81086-6. [DOI] [PubMed] [Google Scholar]
  25. Nishikawa M., Tanaka T., Hidaka H. Ca2+-calmodulin-dependent phosphorylation and platelet secretion. Nature. 1980 Oct 30;287(5785):863–865. doi: 10.1038/287863a0. [DOI] [PubMed] [Google Scholar]
  26. O'Flaherty J. T., Jacobson D. P., Redman J. F. Bidirectional effects of protein kinase C activators. Studies with human neutrophils and platelet-activating factor. J Biol Chem. 1989 Apr 25;264(12):6836–6843. [PubMed] [Google Scholar]
  27. O'Flaherty J. T., Surles J. R., Redman J., Jacobson D., Piantadosi C., Wykle R. L. Binding and metabolism of platelet-activating factor by human neutrophils. J Clin Invest. 1986 Aug;78(2):381–388. doi: 10.1172/JCI112588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Shukla S. D., Morrison W. J., Dhar A. Desensitization of platelet-activating factor-stimulated protein phosphorylation in platelets. Mol Pharmacol. 1989 Apr;35(4):409–413. [PubMed] [Google Scholar]
  29. Shukla S. D., Morrison W. J., Klachko D. M. Response to platelet-activating factor in human platelets stored and aged in plasma. Decrease in aggregation, phosphoinositide turnover, and receptor affinity. Transfusion. 1989 Jul-Aug;29(6):528–533. doi: 10.1046/j.1537-2995.1989.29689318453.x. [DOI] [PubMed] [Google Scholar]
  30. Siess W., Weber P. C., Lapetina E. G. Activation of phospholipase C is dissociated from arachidonate metabolism during platelet shape change induced by thrombin or platelet-activating factor. Epinephrine does not induce phospholipase C activation or platelet shape change. J Biol Chem. 1984 Jul 10;259(13):8286–8292. [PubMed] [Google Scholar]
  31. Stewart A. G., Dusting G. J. Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages. Br J Pharmacol. 1988 Aug;94(4):1225–1233. doi: 10.1111/j.1476-5381.1988.tb11642.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Svec F. Relationship between intact cell ATP levels and glucocorticoid receptor-binding capacity in the AtT-20 cell. Biochim Biophys Acta. 1985 Oct 30;847(1):147–154. doi: 10.1016/0167-4889(85)90167-3. [DOI] [PubMed] [Google Scholar]
  33. Tahraoui L., Floch A., Cavero I. Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets. J Pharmacol Exp Ther. 1990 Mar;252(3):1221–1227. [PubMed] [Google Scholar]
  34. Tyers M., Rachubinski R. A., Stewart M. I., Varrichio A. M., Shorr R. G., Haslam R. J., Harley C. B. Molecular cloning and expression of the major protein kinase C substrate of platelets. Nature. 1988 Jun 2;333(6172):470–473. doi: 10.1038/333470a0. [DOI] [PubMed] [Google Scholar]
  35. Ukena D., Dent G., Birke F. W., Robaut C., Sybrecht G. W., Barnes P. J. Radioligand binding of antagonists of platelet-activating factor to intact human platelets. FEBS Lett. 1988 Feb 15;228(2):285–289. doi: 10.1016/0014-5793(88)80017-6. [DOI] [PubMed] [Google Scholar]
  36. Ukena D., Krogel C., Dent G., Yukawa T., Sybrecht G., Barnes P. J. PAF-receptors on eosinophils: identification with a novel ligand, [3H]WEB 2086. Biochem Pharmacol. 1989 May 15;38(10):1702–1705. doi: 10.1016/0006-2952(89)90322-5. [DOI] [PubMed] [Google Scholar]
  37. Valone F. H. Inhibition of platelet-activating factor binding to human platelets by calcium channel blockers. Thromb Res. 1987 Mar 1;45(5):427–435. doi: 10.1016/0049-3848(87)90306-9. [DOI] [PubMed] [Google Scholar]
  38. Veigl M. L., Klevit R. E., Sedwick W. D. The uses and limitations of calmodulin antagonists. Pharmacol Ther. 1989;44(2):181–239. doi: 10.1016/0163-7258(89)90066-1. [DOI] [PubMed] [Google Scholar]
  39. Verhoeven A. J., Mommersteeg M. E., Akkerman J. W. Metabolic energy is required in human platelets at any stage during optical aggregation and secretion. Biochim Biophys Acta. 1984 Aug 21;800(3):242–250. doi: 10.1016/0304-4165(84)90402-1. [DOI] [PubMed] [Google Scholar]
  40. Winicov I., Gershengorn M. C. Sphingosine inhibits thyrotropin-releasing hormone binding to pituitary cells by a mechanism independent of protein kinase C. J Biol Chem. 1988 Sep 5;263(25):12179–12182. [PubMed] [Google Scholar]
  41. Yamazaki M., Gomez-Cambronero J., Durstin M., Molski T. F., Becker E. L., Sha'afi R. I. Phorbol 12-myristate 13-acetate inhibits binding of leukotriene B4 and platelet-activating factor and the responses they induce in neutrophils: site of action. Proc Natl Acad Sci U S A. 1989 Aug;86(15):5791–5794. doi: 10.1073/pnas.86.15.5791. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES